zzlangerhans’ Activity

Sun Aug 24

CAPS Underperform Pitch

zzlangerhans wrote about AASTROM BIOSCIENCES, INC. (ASTM) . 7:14 PM

ASTM Underperform

Bioturds are like snowflakes. While they certainly all have much in common, no two are exactly alike. Aaastrom's little wrinkle is that ever since their 20:1 reverse split a year ago, the stock has been exquisitely sensitive to manipulation in the [more]

Fri Aug 22

CAPS Underperform Pitch Reply

zzlangerhans commented on zzlangerhans's pitch for AMPE. 4:45 PM

Ha, you are so clueless. How's your big investment working out for you?

Caps Pick

zzlangerhans made a pick in CAPS. 9:34 AM

AASTROM BIOSCIENCES, INC. (ASTM) will Underperform the S&P 500

Tue Aug 19

CAPS Underperform Pitch

zzlangerhans wrote about MELA Sciences (MELA) . 12:18 AM

MELA Underperform

I recently stopped by Mela again and decided it was time for me to drop my 14th red thumb, which will hopefully be sufficient to put me back into score leadership. Mela has relaunched their MelaFind device, this time for sale rather than for lease, [more]

Mon Aug 18

Caps Pick

zzlangerhans made a pick in CAPS. 1:14 PM

MELA Sciences (MELA) will Underperform the S&P 500

Sun Aug 17

CAPS Outperform Pitch Reply

zzlangerhans commented on zzlangerhans's pitch for LJPC. 10:46 PM

Thanks, that's very useful. I'll need to check it through but I have 10 hour shifts today, tomorrow, and Tuesday after which I'm flying to London for a week. Hopefully I'll find enough downtime to get this resolved.

CAPS Underperform Pitch

zzlangerhans wrote about Vanda Pharmaceuticals, Inc. (VNDA) . 12:41 AM

VNDA Underperform

I do enjoy slapping red thumbs on Vanda, although I'm always hesitant to do so because the stock invariably jumps immediately afterwards. Vanda released their first quarter of earnings since the launch of Hetlioz a couple of weeks ago. I was [more]

Sat Aug 16

CAPS Outperform Pitch

zzlangerhans wrote about APPLIED GENETIC TECHNOLOGIES CORP COM USD0.001 (AGTC) . 7:38 PM

AGTC Outperform

As with my recent pick and zzporte purchase Avalanche Biotechnologies, I have little on which to base a positive opinion of Applied Genetic Technologies. Similarly to Avalanche, Applied Genetic is developing AAV-based gene therapies for eye diseases. [more]

Caps Pick

zzlangerhans made a pick in CAPS. 7:38 PM

APPLIED GENETIC TECHNOLOGIES CORP COM USD0.001 (AGTC) will Outperform the S&P 500

CAPS Outperform Pitch Reply

zzlangerhans commented on zzlangerhans's pitch for LJPC. 1:36 PM

I have a hard time seeing how standard error applies here. My understanding is that standard error is a measurement used to assess the accuracy of a sample drawn from a larger population by calculating the error between means from random samples. [more]

Fri Aug 15

CAPS Outperform Pitch Reply

zzlangerhans commented on zzlangerhans's pitch for LJPC. 9:06 PM

IvorOShea - thanks for the link to the phase IIa trial protocol. I'll draw your attention to section 12.6 on page 47. 12.6 Sample Size Estimation To assess the primary efficacy endpoint, the mean change in eGFR from baseline to the average of Day 50 [more]

CAPS Outperform Pitch Reply

zzlangerhans commented on zzlangerhans's pitch for LJPC. 12:23 PM

I'm glad to get a well-thought out reply rather than the vitriol I expected. I'll focus on your second point since the central issue here is the p value and statistical significance of the trial (or lack thereof), not secondary or peripheral [more]

Caps Pick

zzlangerhans made a pick in CAPS. 10:51 AM

Vanda Pharmaceuticals, Inc. (VNDA) will Underperform the S&P 500

CAPS Outperform Pitch

zzlangerhans wrote about La Jolla Pharmaceutical Company (LJPC) . 12:24 AM

LJPC Outperform

Hold on to your hats, folks. This is going to be a wild ride. La Jolla Pharmaceuticals was one of the first biopharma stocks I ever analyzed, back in April of 2007. At that time they were developing a drug called Riquent for lupus. The stock wavered [more]

Wed Aug 13

Caps Pick

zzlangerhans made a pick in CAPS. 1:44 PM

La Jolla Pharmaceutical Company (LJPC) will Outperform the S&P 500

Fri Aug 8

CAPS Outperform Pitch

zzlangerhans wrote about AQUINOX PHARMACEUT (AQXP) . 11:11 PM

AQXP Outperform

My main problem with Aquinox is that they didn't choose the ticker symbol AQAP. Then I could have both AQAP and ISIS on my watchlist and explore the possibility of starting a Jihadist biotech fund. Anyway, Aquinox has been stinking up the tape since [more]

Caps Pick

zzlangerhans made a pick in CAPS. 10:58 AM

AQUINOX PHARMACEUT (AQXP) will Outperform the S&P 500

Blog Comment

zzlangerhans commented on embodiedheart's blog post. 9:47 AM

what happened to the fool commentary?

This is likely the "not logged in" bug. If you look at the top of the stock page where you don't see any commentary, it will appear as though you are not logged in. No matter how many times you log in, this will not

[more]

Thu Aug 7

CAPS Outperform Pitch

zzlangerhans wrote about Avalanche Biotechnologies, Inc. (AAVL) . 7:57 PM

AAVL Outperform

I found myself with a sudden deficit in knowledge about the recent IPO Avalanche after Portefeuille requested that I take a small position of 200 shares at 22.5 for the zzporte portfolio this week. After an hour or two of investigation into the [more]

Caps Pick

zzlangerhans made a pick in CAPS. 12:51 PM

Avalanche Biotechnologies, Inc. (AAVL) will Outperform the S&P 500
Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating 99.78
Player Rank 164 out of 75032
Score 6272.96
Score Change Today 0
Accuracy 82.21%
Active Picks 166
Total Picks 1936
Best Pick BDSI (+1070.42)
Worst Pick PCYC (-2886.09)
Average Score per Pick 3.24
Charms Earned 15
Highest Rated Favorite portefeuille
Go to zzlangerhans’ CAPS page

Boards Stats & Trivia

Board Posts 0
Recs Received 0
People who have rec'd these posts 0
Recs to Posts Ratio (last 30 days) N/A
Threads Started 0
Threads Started Percentage 0.00 %
Most Frequent Board N/A
Very First Post N/A
Percentage of Posts Rec'd 100.00 %
Show zzlangerhans’ 10 Latest Posts